To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
Max Planck Institute Purchases Automation Technology from Formulatrix
Read time: Less than a minute
According to Formulatrix, the department of Biophysical chemistry has successfully deployed Rock Maker and Rock Imager for automation of protein crystallization.
Martin Kollmar, group leader of Biophysical Chemistry department at MPI said, "We were looking for a software solution that not only allows for designing and tracking of crystallization experiments, but also operates liquid handling and imaging robots.
As far as we know, Rock Maker is the only software on the market that solves this problem. In addition, Formulatrix builds an imaging robot that provides very good pictures of crystallization drops from all kinds of 96-well plates. We are very happy that Formulatrix was able to deliver a customized solution, and that we get immediate support."
Jeremy Stevenson, founder and CEO of Formulatrix stated "We are very pleased to add Max Planck to our growing list of customers, especially as a key reference site for the European market."
Formulatrix specializes in providing technology that automates the protein crystallization process, a key part of structure based drug discovery.
Martin Kollmar, group leader of Biophysical Chemistry department at MPI said, "We were looking for a software solution that not only allows for designing and tracking of crystallization experiments, but also operates liquid handling and imaging robots.
As far as we know, Rock Maker is the only software on the market that solves this problem. In addition, Formulatrix builds an imaging robot that provides very good pictures of crystallization drops from all kinds of 96-well plates. We are very happy that Formulatrix was able to deliver a customized solution, and that we get immediate support."
Jeremy Stevenson, founder and CEO of Formulatrix stated "We are very pleased to add Max Planck to our growing list of customers, especially as a key reference site for the European market."
Formulatrix specializes in providing technology that automates the protein crystallization process, a key part of structure based drug discovery.
